ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2013
Impacts of international sanctions on Iranian pharmaceutical market.
Article in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.
- Assessment of the Effects of Economic Sanctions on Iranians' Right to Health by Using Human Rights Impact Assessment Tool: A Systematic Review.International journal of health policy and management · 2018Pooled it
- Customized pharmacological approach to acute and post-operative dental pain control in Iran: guideline review and adaptation.BMC oral health · 2026Article
- Evaluating the Role of the Strategic Level of the National Drug Regulatory Authority in Enhancing Medication Adherence in Cardiovascular Patients: An Importance-Performance Analysis Approach.Research in heart yield and translational medicine · 2026Article
- The Impact of Economic Sanctions on Health and Strategies for Mitigation: A Glance at the Case of Iran.International journal of preventive medicine · 2025Review
- Stakeholder-Driven Cost Management Approaches in Iranian Hospitals: A Qualitative Thematic Analysis.Medical journal of the Islamic Republic of Iran · 2025Article
- Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model.Cost effectiveness and resource allocation : C/E · 2024Article
- Social determinants of health inequity in Iran: a narrative review.Journal of diabetes and metabolic disorders · 2023Review
- Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018.BMC pediatrics · 2023Article
- Psychosocial comorbidities of diabetes during the COVID-19 pandemic in Iran.Journal of education and health promotion · 2023Article
- Health system to response to economic sanctions: global evidence and lesson learned from Iran.Globalization and health · 2022Review
- COVID-19 management in Iran and international sanctions.European journal of translational myology · 2022Review
- Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector.Research in pharmaceutical sciences · 2022Article
- Challenge of Politico-Economic Sanctions on Pharmaceutical Procurement in Iran: A Qualitative Study.Iranian journal of medical sciences · 2022Article
- Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.Health research policy and systems · 2021Article
- Underlying factors and challenges of implementing the urban family physician program in Iran.BMC health services research · 2021Article
- Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran.Journal of pharmaceutical policy and practice · 2021Article
- COVID-19 battle during the toughest sanctions against Iran.Lancet (London, England) · 2020Article
- The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016.Journal of pharmaceutical policy and practice · 2020Article
- How health transformation plan was designed and implemented in the Islamic Republic of Iran?International journal of preventive medicine · 2020Article
- Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iran in recent decade faced several regional and international sanctions in foreign trade, financial and banking services. Iran national pharmaceutical industry has always played a major role in providing medicines to the Iranian patients. However, following the sanctions it has faced profound difficulties for importing of both finished products and pharmaceutical raw materials. Although medicines are exempted from sanctions, due to restriction on money transaction and proper insurance Iranian pharmaceutical companies have to pay cash in advance for imports of medicines and raw materials or to secure offshore funds at very high risks. Current situation in Iran pharmaceutical market confirms that the sanctions against Iran are affecting ordinary citizens and national health sector which resulted to reduction of availability of lifesaving medicines in the local market and has caused increasing pain and suffering for Iranian patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.